This website is best viewed using the vertical display on your mobile device.
SPRYCEL® (dasatinib) is indicated for the treatment of adult patients with:
SPRYCEL® is indicated for the treatment of pediatric patients 1 year of age and older with:
Tablet dosing for pediatric patients1
Tablet dosing is not recommended for patients weighing less than 10 kg.
*Aged 1 year or older.
IMPORTANT SAFETY INFORMATION ABOUT DRUG INTERACTIONS
Effect of Other Drugs on Dasatinib